Real‐world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta‐analysis
D Charles, J Shanley, SN Temple… - Clinical & …, 2022 - Wiley Online Library
Background Severe asthma is a major cause of morbidity. Some patients may benefit from
biological therapies. Most evaluations of these treatments are derived from randomized …
biological therapies. Most evaluations of these treatments are derived from randomized …
[HTML][HTML] Future risks in patients with severe asthma
WJ Song, JH Lee, Y Kang, WJ Joung… - Allergy, Asthma & …, 2019 - ncbi.nlm.nih.gov
A major burden of severe asthma is the future risk of adverse health outcomes. Patients with
severe asthma are prone to serious exacerbation and deterioration of lung function and may …
severe asthma are prone to serious exacerbation and deterioration of lung function and may …
Occupational exposure to disinfectants and asthma control in US nurses
O Dumas, AS Wiley, C Quinot, R Varraso… - European …, 2017 - Eur Respiratory Soc
Disinfectant use has been associated with adverse respiratory effects among healthcare
workers. However, the specific harmful agents have not been elucidated. We examined the …
workers. However, the specific harmful agents have not been elucidated. We examined the …
Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression
E Ramos-Martínez, MR López-Vancell… - Cytokine, 2018 - Elsevier
Background Vitamin D is a molecule that modulates the immune response and shows anti-
inflammatory effects that are beneficial for the control of chronic diseases such as asthma …
inflammatory effects that are beneficial for the control of chronic diseases such as asthma …
Approaches to the assessment of severe asthma: barriers and strategies
EC Majellano, VL Clark, NA Winter… - Journal of asthma …, 2019 - Taylor & Francis
Asthma is a chronic condition with great variability. It is characterized by intermittent
episodes of wheeze, cough, chest tightness, dyspnea and backed by variable airflow …
episodes of wheeze, cough, chest tightness, dyspnea and backed by variable airflow …
Normalizing fibromyalgia as a chronic illness
DJ Clauw, Y D'Arcy, K Gebke, D Semel… - Postgraduate …, 2018 - Taylor & Francis
Fibromyalgia (FM) is a complex chronic disease that affects 3–10% of the general adult
population and is principally characterized by widespread pain, and is often associated with …
population and is principally characterized by widespread pain, and is often associated with …
Chronic rhinosinusitis disease control: a review of the history and the evidence
AR Sedaghat, KM Phillips - Expert Review of Clinical Immunology, 2023 - Taylor & Francis
Introduction Control is an important concept and outcome measure for chronic incurable
diseases, defined as the extent to which manifestations of a disease are within acceptable …
diseases, defined as the extent to which manifestations of a disease are within acceptable …
Household Use of Green Cleaning Products, Disinfecting Wipes, and Asthma Control Among Adults
EP Da Silva, R Varraso, AM Lenzotti, LK Fezeu… - The Journal of Allergy …, 2024 - Elsevier
Background The use of household disinfectants and cleaning products (HDCPs) may
negatively impact asthma control, but studies remain scarce. Moreover, no study considered …
negatively impact asthma control, but studies remain scarce. Moreover, no study considered …
Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma
P Katsaounou, M Odemyr, O Spranger… - ERJ open …, 2018 - Eur Respiratory Soc
We conducted a large global survey, Still Fighting for Breath, in patients with severe
persistent asthma, 10 years after the Fighting for Breath survey to assess the impact of …
persistent asthma, 10 years after the Fighting for Breath survey to assess the impact of …
[HTML][HTML] Personal exposure to fine particulate matter (PM2. 5) and self-reported asthma-related health
Abstract PM 2.5 (fine particulate matter≤ 2.5 μm in diameter) is a key pollutant that can
produce acute asthma exacerbations and longer-term deterioration of respiratory health …
produce acute asthma exacerbations and longer-term deterioration of respiratory health …